Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
05:15am, Tuesday, 25'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
BIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit
05:00am, Tuesday, 25'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Bi
Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors - Contact Levi & Korsinsky
07:45pm, Monday, 24'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Co
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
06:18pm, Monday, 24'th Jun 2024
Investors can contact the law firm at no cost to learn more about recovering their losses.
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIIB
04:20pm, Monday, 24'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB)
02:30pm, Monday, 24'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc. (BIIB)
02:30pm, Monday, 24'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK , June 24, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The cla
Biogen Inc. (BIIB) is a Top-Ranked Momentum Stock: Should You Buy?
10:55am, Monday, 24'th Jun 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
07:30am, Monday, 24'th Jun 2024
Cambridge, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the European Commission (EC) has granted approval for TOFIDENCETM, a biosimilar monoclonal antibody refe
Shareholders that lost money on Biogen Inc.(BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB
05:15am, Monday, 24'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
